Cold-Form Blister Foil: Market Size & Forecast 2026

The global cold-form blister foil market sits at approximately USD 2.4 billion in 2025 (base year), anchored by pharmaceutical demand that treats this format as the non-negotiable barrier standard for moisture-sensitive active pharmaceutical ingredients. The market grows at a 6.8 percent CAGR through 2032, reaching roughly USD 3.8 billion, driven by generic pharma export volumes from India and China into ICH Q1A Zone IVb stability destinations rather than any structural shift in pharmaceutical packaging paradigms. > **Analyst Take.** The call is not whether cold-form grows; it is whether buyers are pricing the right risk. A 6.5 percent CAGR is sustainable because generic pharma exports to Zone IVb markets have structural momentum, but anyone treating this as a commoditised flexible packaging category will misprice the switching cost. The right sequence is: dual-source two converters now,

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.